I now have sufficient information from authoritative sources to provide a comprehensive answer. Let me compile everything.
HELLP Syndrome: Anaesthetic Management
What is HELLP Syndrome?
HELLP (Haemolysis, Elevated Liver enzymes, Low Platelets) is considered a variant of preeclampsia with severe features. Key features:
- H — Haemolysis (microangiopathic)
- EL — Elevated liver enzymes (AST/ALT; rarely exceed 500 IU/L)
- LP — Low platelets (<100,000/mm³)
Severe hypertension may be absent in some cases. Occurs in ~10% of severe preeclampsia cases. Importantly, 20% of cases develop postpartum, so surveillance continues after delivery.
Anaesthetic Considerations
1. Pre-operative Assessment
| Parameter | Significance |
|---|
| Platelet count | Critical before any neuraxial technique |
| Liver enzymes | Altered drug metabolism, coagulopathy risk |
| Coagulation screen | DIC can complicate HELLP |
| Airway | Oedema from preeclampsia/magnesium; full obstetric airway assessment |
| Blood pressure | Target SBP <160 mmHg, DBP <110 mmHg |
| Renal function | Creatinine >1.1 mg/dL or doubling = severe feature |
| Serum magnesium | If on therapy — potentiates neuromuscular blockade |
2. Regional vs. General Anaesthesia
Regional anaesthesia is the preferred technique for labour and delivery in preeclampsia/HELLP, provided coagulopathy permits.
Advantages of neuraxial anaesthesia:
- Best quality pain relief
- Attenuates hypertensive responses to pain
- Reduces circulating catecholamines
- Does not require fluid preload with dilute local anaesthetic/opioid solutions
- Avoids the hazards of general anaesthesia (difficult airway, aspiration, hypertensive response to laryngoscopy)
"Regional anesthesia is the preferred technique for patients with preeclampsia for labor and delivery." — Miller's Anesthesia, 10e
3. Platelet Thresholds for Neuraxial Anaesthesia
This is the most critical anaesthetic issue in HELLP syndrome:
| Platelet Count | Neuraxial Risk | Recommendation |
|---|
| ≥70,000/mm³ | Very low risk | Safe; recommended threshold for obstetric neuraxial (SOAP consensus) |
| 50,000–69,000/mm³ | ~3% upper bound for epidural haematoma | Individualised decision |
| <50,000/mm³ | Up to 11% risk | Generally avoided; consider GA |
"The SOAP interdisciplinary consensus statement on neuraxial procedures in patients with thrombocytopenia concluded the best available evidence indicates a very low risk of neuraxial hematoma was associated with a platelet count of ≥70,000/mm³." — Miller's Anesthesia, 10e
- The older threshold of 100,000/mm³ has been challenged; 70,000/mm³ is now the accepted safe threshold for obstetric neuraxial procedures
- There is no universally accepted platelet count; decision must incorporate rate of fall, trend, other coagulation abnormalities, and clinical context
- No single platelet function test reliably predicts bleeding risk after regional anaesthesia
4. General Anaesthesia — When Required
Indications: platelet count <70,000/mm³, active coagulopathy, DIC, patient refusal of regional, or failed regional.
Key concerns:
- Difficult/failed intubation: Increased risk in obstetrics; airway oedema is worsened in preeclampsia. A clear algorithm for failed intubation must be in place.
- Aspiration risk: Full stomach; RSI with cricoid pressure
- Hypertensive response to laryngoscopy: Dangerous in these patients — blunt with remifentanil, esmolol, lignocaine, or magnesium bolus
- Magnesium interactions:
- Potentiates non-depolarising neuromuscular blockers — reduce dose and monitor with nerve stimulator
- Suxamethonium may have prolonged action — reduced pseudocholinesterase activity is reported in HELLP syndrome
- Succinylcholine: Reduced plasma pseudocholinesterase activity documented in HELLP syndrome may prolong block
- Volatile agents: Avoid in the presence of coagulopathy/DIC if possible (may worsen uterine atony)
5. Blood Pressure Management
- Treat SBP ≥160 mmHg or DBP ≥110 mmHg to prevent intracerebral haemorrhage, myocardial ischaemia, renal injury, and heart failure
- First-line agents: IV labetalol, IV hydralazine, oral nifedipine
- Patients with HELLP/preeclampsia are sensitive to both endogenous and exogenous catecholamines — careful use of vasopressors
- Methergonovine (ergometrine) is contraindicated — may cause hypertensive crisis; use oxytocin for uterotonic management instead
6. Fluid Management
- Maternal vasculature in preeclampsia is contracted (vasospasm) but porous (endothelial damage) — not simply underfilled
- Aggressive IV fluid administration risks pulmonary oedema (already a severe feature)
- Conservative fluid management: avoid large preloads; use vasopressors (phenylephrine/ephedrine) judiciously for regional-induced hypotension
- Phenylephrine is associated with less foetal acidosis than ephedrine but requires caution given catecholamine sensitivity
7. Magnesium Sulphate
- Indicated for seizure prophylaxis (eclampsia prevention) in preeclampsia/HELLP
- Anaesthetic implications:
- Potentiates neuromuscular blockade — monitor TOF; use reduced doses of NDMR
- May worsen postpartum uterine atony — have oxytocin and additional uterotonics ready
- Side effects: respiratory depression, loss of deep tendon reflexes (early sign of toxicity), cardiac arrest at very high levels
- Antidote: calcium gluconate 1g IV
8. Delivery and Postpartum
- HELLP is an indication for delivery but not necessarily caesarean section — vaginal delivery is acceptable if feasible
- Laboratory abnormalities typically improve within 5 days postpartum, though they may initially worsen
- 20% of HELLP cases develop postpartum — continue monitoring liver enzymes, platelets, and BP after delivery
- If epidural catheter was placed, consider timing of removal carefully against platelet trend (recheck count before removal)
9. Summary of Key Anaesthetic Priorities
- Check and trend platelets — determines regional vs. general approach
- Neuraxial preferred if platelets ≥70,000/mm³ and no active coagulopathy
- Control blood pressure before induction/intubation
- Prepare for difficult airway — always
- Account for magnesium — adjust NDMR dosing, monitor TOF
- Avoid Methergine — use oxytocin for uterotonic management
- Conservative fluid strategy — pulmonary oedema risk
- Postpartum surveillance continues — HELLP can develop or worsen after delivery
Sources: Miller's Anesthesia, 10e; Creasy & Resnik's Maternal–Fetal Medicine, 8e